Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.
Living with chronic pain not only drags down quality of life, but it is also linked to poorer HIV-related health outcomes.
That’s compared with HIV-negative men.
AZT and ddI were the main drugs associated with liver damage in a new study.
Long-term Viread (tenofovir disoproxil fumarate, or TDF) use is linked with a raised risk of end-stage liver cancer in HIV-positive people.
People treated with some of the older versions of a class of HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs) were more...
The nucleoside analogue Videx EC (didanosine) is associated with a liver disorder called non-cirrhotic portal hypertension, according to...
Distal sensory polyneuropathy (DSPN)—a type of nerve damage that can lead to tingling and pain in the feet and hands—affects more...
Working out with weights and maintaining high albumin levels protected against bone loss, while completing menopause or taking tenofovir (foun...
Videx EC, the delayed-release form of Videx, may now be taken by children who weigh at least 44 pounds, according to an update to the drug’s p...
New data from the SMART trial indicate that abacavir is associated with an increased risk of cardiovascular disease.
A monitoring board for an international trial comparing three antiretroviral (ARV) regimens has found that Reyataz (atazanavir) combined with...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.